Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus
Introduction: Quick release bromocriptine (BROM-QR), currently approved for glycemic control, reduces the risk of cardiovascular events in adults with type-2 diabetes mellitus (T2DM). This study evaluates the effect of BROM-QR on homocysteine (HOMC) and high sensitive C-reactive protein (hs-CRP), th...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2016-03-01
|
Series: | Journal of Cardiovascular and Thoracic Research |
Subjects: | |
Online Access: | http://journals.tbzmed.ac.ir/JCVTR/Manuscript/JCVTR-8-8.pdf |